Prexige - COX-2 Inhibitor for the Relief of Pain and Inflammation
Key Data:
Drug (brand/generic)
Prexige (lumiracoxib)
Company/licensee
Novartis
Therapy class
Selective COX-2 inhibitor
Product description
Inhibits the action of the COX-2 isoenzyme
Current indication
Treatment of pain and inflammation
Market sector
CNS - pain
Development status
Withdrawn from all major markets
